Framework Journal · one stock, one dated entry

Recorded 2026-08-14 · Permanent

Lichen International Ltd LICN

Clears both ethical standards

An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.

In plain words · Lichen International Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China.

The label
Markup

read at $1.34

Lichen International Ltd holds its Markup at $1.34.

PHINPOOPSC
  • PHPhase · the trend structure carries the Markup label
  • INInsiders · no filings inside 60 days, left as found
  • POPositioning · no disclosures inside 60 days, left as found
  • OPOptions · no verdict drawn today, left as found
  • SCScreen · passes the values gate
  • edge confirmed
  • edge broken
  • edge forming

Each arm is one independent read. Conviction is not a single call, it is how many edges converge.

The investor read · the season, not the day

As held on the ledger · 2026-08-14
PhaseMarkup
Quantitative stateElevated stress, defensive posture warranted, held for 52 days
Price$1.34
ValuationN/A trailing · N/A forward price to earnings
Values screenPASS · score 70.0
Beta-1.12

The business, in plain words · what the numbers mean

The fundamentals · plain-English read
Revenue growth-56.1%
revenue is shrinking
Profit margin-89.6%
currently unprofitable
Return on equity-29.8%
not currently earning a positive return on equity
Debt to equity0.79
moderate, manageable leverage
Current ratio7.73
comfortably covers its short-term bills
Beta-1.12
barely tracks the market's swings
Market cap$22M
Employees410

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to China and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Related securities · others in LICN's space worth a look

Screened names in the same industry · explore each on its own page.

The trader read · the latest dated commentary

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 52.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 42%. Our forward projection puts the odds of a 10% gain over the next month near 23%. Entered 2026-08-04 · Markup

The dated journal · newest first, never edited

2026-08-04 Markup · changed $1.35 -52.1% Entry 4

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 52.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 42%. Our forward projection puts the odds of a 10% gain over the next month near 23%.

2026-07-18 Distribution $2.82 +0.0% Entry 3

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 42%. Our forward projection puts the odds of a 10% gain over the next month near 23%.

2026-07-03 Distribution $2.82 +0.0% Entry 2

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.

2026-07-02 Distribution $2.82 Entry 1

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What holding actually paid · price plus dividends

If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $8.02 -70.6% · $294 -70.6%
2 months $3.19 -26.2% · $738 -26.2%
3 months $3.01 -21.8% · $782 -21.8%
6 months $3.25 -27.5% · $725 -27.5%
1 year $4.08 -42.3% · $577 -42.3%
2 years $1.39 +69.4% · $1,694 +69.4%
3 years $1.92 +22.7% · $1,227 +22.7%

Historical returns from market close data. Past performance does not guarantee future results.

This entry now belongs to the ledger. Whatever LICN does next, these words stay.

Lichen International Ltd · LICN · Markup · $1.34
Recorded 2026-08-14 · before the outcome · scored mechanically

Get our weekly market brief free.